rs6979

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001082486.2(ACD):​c.1295T>C​(p.Val432Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.497 in 1,613,744 control chromosomes in the GnomAD database, including 209,358 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V432I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.60 ( 29938 hom., cov: 32)
Exomes 𝑓: 0.49 ( 179420 hom. )

Consequence

ACD
NM_001082486.2 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -0.0910

Publications

65 publications found
Variant links:
Genes affected
ACD (HGNC:25070): (ACD shelterin complex subunit and telomerase recruitment factor) This gene encodes a protein that is involved in telomere function. This protein is one of six core proteins in the telosome/shelterin telomeric complex, which functions to maintain telomere length and to protect telomere ends. Through its interaction with other components, this protein plays a key role in the assembly and stabilization of this complex, and it mediates the access of telomerase to the telomere. Multiple transcript variants encoding different isoforms have been found for this gene. This gene, which is also referred to as TPP1, is distinct from the unrelated TPP1 gene on chromosome 11, which encodes tripeptidyl-peptidase I. [provided by RefSeq, Jul 2008]
CARMIL2 (HGNC:27089): (capping protein regulator and myosin 1 linker 2) This gene encodes a member of the CARMIL (capping protein, Arp2/3, myosin-I linker) family of proteins. The encoded protein interacts with and negatively regulates the heterodimeric capping protein and promotes cell migration. Reduced expression of this gene has been observed in human psoriasis patients. Mutations in this gene cause a human immunodeficiency syndrome characterized by smooth muscle tumors and impaired T-cell function. [provided by RefSeq, May 2017]
CARMIL2 Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to CARMIL2 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0911076E-6).
BP6
Variant 16-67657765-A-G is Benign according to our data. Variant chr16-67657765-A-G is described in ClinVar as Benign. ClinVar VariationId is 1167321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.885 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACDNM_001082486.2 linkc.1295T>C p.Val432Ala missense_variant Exon 11 of 12 ENST00000620761.6 NP_001075955.2 Q96AP0-3
CARMIL2NM_001013838.3 linkc.*247A>G downstream_gene_variant ENST00000334583.11 NP_001013860.1 Q6F5E8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACDENST00000620761.6 linkc.1295T>C p.Val432Ala missense_variant Exon 11 of 12 1 NM_001082486.2 ENSP00000478084.1 Q96AP0-3
CARMIL2ENST00000334583.11 linkc.*247A>G downstream_gene_variant 1 NM_001013838.3 ENSP00000334958.5 Q6F5E8-1

Frequencies

GnomAD3 genomes
AF:
0.595
AC:
90426
AN:
151964
Hom.:
29887
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.893
Gnomad AMI
AF:
0.497
Gnomad AMR
AF:
0.510
Gnomad ASJ
AF:
0.567
Gnomad EAS
AF:
0.153
Gnomad SAS
AF:
0.557
Gnomad FIN
AF:
0.525
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.569
GnomAD2 exomes
AF:
0.501
AC:
125898
AN:
251212
AF XY:
0.501
show subpopulations
Gnomad AFR exome
AF:
0.900
Gnomad AMR exome
AF:
0.436
Gnomad ASJ exome
AF:
0.552
Gnomad EAS exome
AF:
0.151
Gnomad FIN exome
AF:
0.513
Gnomad NFE exome
AF:
0.493
Gnomad OTH exome
AF:
0.522
GnomAD4 exome
AF:
0.486
AC:
710713
AN:
1461662
Hom.:
179420
Cov.:
62
AF XY:
0.489
AC XY:
355463
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.910
AC:
30477
AN:
33480
American (AMR)
AF:
0.448
AC:
20037
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.560
AC:
14630
AN:
26136
East Asian (EAS)
AF:
0.155
AC:
6160
AN:
39700
South Asian (SAS)
AF:
0.564
AC:
48647
AN:
86250
European-Finnish (FIN)
AF:
0.512
AC:
27294
AN:
53310
Middle Eastern (MID)
AF:
0.615
AC:
3547
AN:
5768
European-Non Finnish (NFE)
AF:
0.476
AC:
529482
AN:
1111918
Other (OTH)
AF:
0.504
AC:
30439
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
22130
44259
66389
88518
110648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15594
31188
46782
62376
77970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.595
AC:
90532
AN:
152082
Hom.:
29938
Cov.:
32
AF XY:
0.593
AC XY:
44107
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.893
AC:
37074
AN:
41518
American (AMR)
AF:
0.509
AC:
7779
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.567
AC:
1968
AN:
3470
East Asian (EAS)
AF:
0.154
AC:
795
AN:
5168
South Asian (SAS)
AF:
0.554
AC:
2670
AN:
4820
European-Finnish (FIN)
AF:
0.525
AC:
5548
AN:
10572
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.483
AC:
32838
AN:
67948
Other (OTH)
AF:
0.574
AC:
1212
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1611
3221
4832
6442
8053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.521
Hom.:
58211
Bravo
AF:
0.601
TwinsUK
AF:
0.467
AC:
1733
ALSPAC
AF:
0.462
AC:
1782
ESP6500AA
AF:
0.885
AC:
3889
ESP6500EA
AF:
0.489
AC:
4205
ExAC
AF:
0.515
AC:
62557
Asia WGS
AF:
0.450
AC:
1568
AN:
3478
EpiCase
AF:
0.503
EpiControl
AF:
0.502

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Dyskeratosis congenita, autosomal dominant 6 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied by a panel of primary immunodeficiencies. Number of patients: 65. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.5
DANN
Benign
0.77
DEOGEN2
Benign
0.11
.;T;T;T;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.0068
N
LIST_S2
Benign
0.21
T;T;.;T;T;.
MetaRNN
Benign
0.0000011
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.90
.;N;.;.;.;.
PhyloP100
-0.091
PrimateAI
Benign
0.32
T
REVEL
Benign
0.035
Sift4G
Benign
0.93
.;T;T;.;T;.
Polyphen
0.0
.;B;.;.;.;B
Vest4
0.058, 0.086, 0.051
MPC
0.11
ClinPred
0.0080
T
GERP RS
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.016
gMVP
0.082
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6979; hg19: chr16-67691668; COSMIC: COSV54667315; COSMIC: COSV54667315; API